Attitudes towards and rationale for antipsychotic polypharmacy among psychiatrists in Nigeria: Characteristics associated with high reported antipsychotic polypharmacy
Nigerian psychiatrists reported using antipsychotic polypharmacy (APP) in 36.2% of patients. ‘High’ (>30%) and ‘lower’ (≤30%) APP prescribers did not differ on concerns about or reasons for APP. ‘Lower’ APP use was associated with having successfully switched patients to monotherapy. ‘High’ APP use was associated with first-generation APP and trying to reduce non-antipsychotics.